The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

The most common blood type among the population in the United States is O-positive. Around 53 percent of the Latino-American population in the U.S. has blood type O-positive, while only around 37 percent of the Caucasian population has this blood type. The second most common blood type in the United States is A-positive. Around 33 percent of the Caucasian population in the United States has A-positive blood type. Blood type O-negative Those with blood type O-negative are universal donors as this type of blood can be used in transfusions for any blood type. O-negative blood type is most common in the U.S. among Caucasian adults. Around eight percent of the Caucasian population has type O-negative blood, while only around one percent of the Asian population has this blood type. Only around seven percent of all adults in the United States have O-negative blood type. Blood Donations The American Red Cross estimates that someone in the United States needs blood every two seconds. However, only around three percent of age-eligible people donate blood yearly. The percentage of adults who donated blood in the United States has not fluctuated much for the past two decades. In 2021, around 15 percent of U.S. adults donated blood, the same share reported in the year 2003.

According to Cognitive Market Research, the global blood group typing market size is USD XX million in 2023 and will expand at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

The global blood group typing market will expand significantly by 8.8% CAGR between 2024 to 2031.
North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Europe accounted for a share of over XX% of the global market size of USD XX million.
Asia Pacific held a market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The blood group typing industry is set to rise due to increased blood group ownership rates, rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce. Increasing online retail channels further bolster demand, while cultural significance and investment appeal contribute to its enduring popularity.
The blood group typing market is driven by rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce.
Antibody Screenings are anticipated to form the majority of blood group owners in the years to come.

Current Scenario of the Blood Group Typing Market

Key Drivers of the Blood Group Typing Market

The growing incidence of chronic illnesses and the increase in surgical operations necessitates the need for blood donations

The demand for blood has grown as chronic diseases and the surgical procedures necessary to treat them have become more common. Blood transfusions are typically necessary for patients with chronic illnesses to manage their symptoms, and large volumes of blood are required for surgical procedures, particularly major surgeries, to ensure safe and effective results. As a result, the need for blood has steadily increased within the healthcare system, which has led to a rise in blood donation rates. The market is anticipated to benefit from this. To treat patients with chronic illnesses and those having difficult surgical operations, the American National Red Cross (2023) estimates that every day, over 29,000 units of red blood cells are required in US hospitals and emergency rooms. For instance, according to the National Center for Biotechnology Information, the number of people 50 years of age and older who have at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase.

Source- https://pubmed.ncbi.nlm.nih.gov/36711415/#:~:text=Of%20the%20population%2050%20years,to%2014.968%20million%20in%202050.

Blood group typing is a necessary test that establishes the Rh factor and the level of blood compatibility between the donor and the recipient prior to blood transfusions. Thus, the need for blood donations is a result of the rising prevalence of chronic illnesses and the rise in surgical procedures.

Blood Donation rates have necessitated the need for Blood Group Typing

Global blood donation rates have significantly increased over time. The need for transfusion procedures such as blood type detection and cross-matching has surged due to a rise in voluntary blood donations. The National Health Service Blood and Transplant (NHSBT) receives over 1.5 million voluntary blood donations annually, which are processed by the government before being given to hospitals and patients in need, according to an article published by the European Blood Alliance (EBA) (2019–2022).

Source- https://www.nhsbt.nhs.uk/who-we-are/a-history-of-donation-transfusion-and-transplantation/

NHSBT supplies hospitals in England with a secure and dependable supply of blood components, diagnostic services, and stem cell treatments. To do this, it depends on 1...

This statistic illustrates the distribution of blood groups in the French population, according to the ABO system. It states that less than **** percent of French people have the AB blood group.

ABO Blood Type Test Kit Market Outlook

The global ABO blood type test kit market size was valued at USD 780 million in 2023 and is projected to reach USD 1.2 billion by 2032, growing at a CAGR of 4.8% during the forecast period. The market for ABO blood type test kits is experiencing robust growth primarily driven by increasing demand for blood transfusion services, advancements in diagnostic technologies, and the rising prevalence of chronic diseases necessitating blood type testing. These factors contribute significantly to the market's expansion and its optimistic outlook.

One of the primary growth factors for the ABO blood type test kit market is the increasing number of surgical procedures and trauma cases worldwide, which demand immediate and accurate blood typing. Additionally, the growing awareness about the importance of blood typing in organ transplantation and prenatal testing further propels the market. The surge in blood donation drives and the need for efficient blood bank management systems, which rely heavily on accurate blood type testing, also significantly contribute to market growth.

Technological advancements in diagnostic techniques, such as the development of rapid test kits that offer quick and reliable results, are another critical driver of market expansion. These innovations have made blood typing more accessible and convenient, particularly in remote and underserved areas. The rising adoption of point-of-care testing, which allows for blood type determination outside traditional laboratory settings, is also enhancing the market's growth prospects.

The increasing prevalence of chronic diseases, such as cancer and kidney disorders, which often require regular blood transfusions, is a significant factor fueling the demand for ABO blood type test kits. Moreover, the aging global population, which is more susceptible to various medical conditions requiring blood transfusions, contributes to the sustained demand for these kits. Public health initiatives and government policies promoting regular health check-ups and blood donation are also playing a crucial role in driving the market forward.

From a regional perspective, North America holds a dominant position in the ABO blood type test kit market due to its well-established healthcare infrastructure, high awareness levels, and significant investments in healthcare technologies. Europe follows closely, driven by similar factors along with a strong focus on research and development. The Asia Pacific region is expected to witness the fastest growth, attributed to its large population base, increasing healthcare expenditures, and rising awareness about blood-related health issues. Other regions, including Latin America and the Middle East & Africa, are also showing promising growth potential due to improving healthcare facilities and increasing government initiatives.

Product Type Analysis

The ABO blood type test kit market is segmented by product type into rapid test kits and laboratory test kits. Rapid test kits are designed for quick and efficient blood typing, providing results in a matter of minutes. These kits are particularly useful in emergency situations, field settings, and for point-of-care testing. The demand for rapid test kits is driven by their ease of use, minimal training requirements, and the ability to deliver immediate results, making them highly suitable for use in various non-laboratory settings.

Laboratory test kits, on the other hand, are designed for use in clinical laboratories and provide highly accurate and reliable results. These kits are typically used in hospitals, diagnostic laboratories, and blood banks where precision is crucial. The demand for laboratory test kits is driven by the increasing number of diagnostic procedures and the need for accurate blood type determination in critical medical situations. These kits often employ advanced technologies such as gel cards and microplates, contributing to their high accuracy and reliability.

The rapid test kits segment is expected to witness significant growth during the forecast period due to the increasing adoption of point-of-care testing and the rising need for quick and efficient blood type determination in emergency and remote settings. The convenience and speed offered by rapid test kits are making them increasingly popular among healthcare providers and individual consumers alike. Additionally, advancements in rapid testing technologies are further enhancing the accuracy and reliability of these kits, contributing to their growing demand.

Blood Type Special Centrifuge Market Outlook

The global blood type special centrifuge market size was valued at approximately USD 1.2 billion in 2023 and is projected to reach nearly USD 2.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This significant growth is driven by an increasing demand for precise blood component separation, rising incidences of blood disorders, and advancing healthcare infrastructure globally.

A major growth factor for the blood type special centrifuge market is the escalating prevalence of blood-related disorders and diseases. Conditions such as anemia, leukemia, and other hematological disorders necessitate the use of specialized centrifuges for accurate diagnosis and treatment. Additionally, the rising number of surgical procedures and the subsequent need for blood transfusions emphasize the importance of efficient blood separation techniques, further driving market demand. Furthermore, advancements in medical technology are enabling the development of more sophisticated and efficient centrifuges, which enhances their adoption in various healthcare settings.

Another critical growth factor is the expanding healthcare infrastructure, particularly in developing regions. Countries in Asia Pacific and Latin America are investing substantially in healthcare facilities and diagnostic laboratories, which in turn increases the demand for advanced medical equipment, including blood type special centrifuges. Additionally, government initiatives and funding aimed at improving healthcare access and quality are positively impacting market growth. For instance, numerous national health programs are focusing on better management of blood banks and transfusion services, which rely heavily on effective centrifugation processes.

The increased focus on research and development in the medical field is also a significant driver of market growth. Research laboratories and academic institutions are increasingly utilizing blood type special centrifuges for various analytical and experimental purposes. The rise in funding for medical research and the growing emphasis on personalized medicine are further contributing to the increasing demand for specialized centrifuges. Moreover, collaborations between universities and commercial entities are fostering innovation in centrifuge technology, leading to the introduction of advanced products in the market.

From a regional perspective, North America holds a substantial share of the blood type special centrifuge market, owing to its well-established healthcare infrastructure, high healthcare spending, and robust presence of key market players. Europe also represents a significant market share, driven by advanced healthcare facilities and increasing focus on research activities. The Asia Pacific region, however, is anticipated to witness the highest growth rate during the forecast period, driven by rapid healthcare advancements and increasing governmental support. This regional growth outlook highlights the global nature of the market's expansion and the diverse factors influencing it.

Product Type Analysis

The blood type special centrifuge market is segmented by product type, which includes benchtop centrifuges, floor-standing centrifuges, high-speed centrifuges, and low-speed centrifuges. Benchtop centrifuges are widely used in various healthcare and research settings due to their compact size and versatility. These centrifuges are particularly popular in smaller laboratories and clinics where space is a constraint. Their ease of use and affordability make them an attractive option for many facilities looking to enhance their diagnostic capabilities without significant financial investment.

Floor-standing centrifuges, on the other hand, are preferred in larger medical and research institutions that require higher capacity and performance. These centrifuges are designed to handle larger volumes of samples and offer superior speed and efficiency compared to benchtop models. The advancements in automation and digital integration in floor-standing centrifuges are driving their adoption in settings where high throughput and precision are critical. Additionally, these centrifuges are often equipped with advanced safety features, making them suitable for handling infectious or hazardous samples.

High-speed centrifuges are another key segment in the market, primarily used for applications requiring rapid separation of blood components. These centrifuges are capable of achieving very high rotational speeds, which significantly

In 2021, there were an estimated 45,142 blood transfusion-associated adverse reactions in the United States that required any diagnostic or therapeutic intervention. This graph shows the estimated number of blood transfusion-associated adverse reactions in the United States in 2019 and 2021, by type.

Snapshot img

Blood-Grouping Reagents Market Size 2025-2029

The blood-grouping reagents market size is valued to increase USD 611.8 million, at a CAGR of 8.8% from 2024 to 2029. Increasing prevalence of chronic disorders will drive the blood-grouping reagents market.

Major Market Trends & Insights

North America dominated the market and accounted for a 49% growth during the forecast period.
By End-user - Hospitals and blood banks segment was valued at USD 424.40 million in 2023
By Technique - PCR-based and microarray techniques segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 115.97 million
Market Future Opportunities: USD 611.80 million
CAGR from 2024 to 2029 : 8.8%

Market Summary

The market is a significant segment of the diagnostics industry, driven by the increasing prevalence of chronic disorders and the advancements in diagnostic devices. These reagents play a crucial role in identifying the blood types of donors and recipients for transfusions, ensuring compatibility and minimizing the risks associated with incompatible blood types. The market size was valued at USD 1.5 billion in 2020 and is expected to grow at a steady pace due to the rising demand for safe and efficient blood transfusions. The market's growth is underpinned by advancements in technology, including the development of rapid and automated blood-grouping systems, which offer faster and more accurate results. These advancements are expected to further boost market growth, enabling healthcare providers to offer faster and more efficient diagnostic services.
Additionally, the increasing incidence of chronic diseases, such as cancer and hemorrhagic disorders, necessitates a larger supply of safe blood, further fueling market growth. However, challenges persist, including the need for standardization and the high cost of advanced blood-grouping technologies. Despite these challenges, the market is expected to continue its expansion, driven by the growing need for safe and efficient blood transfusions.

What will be the Size of the Blood-Grouping Reagents Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Blood-Grouping Reagents Market Segmented ?

The blood-grouping reagents industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and blood banks
  Clinical laboratories
  Academic and research institutes


Technique

  PCR-based and microarray techniques
  Assay-based techniques
  Massively parallel sequencing techniques
  Serology


Product

  Anti-sera reagents
  Red blood cell reagents
  Blood bank saline
  Others


Test Type

  Blood Grouping & Phenotyping
  Antibody Screening
  Cross-matching Tests
  Coombs Tests
  Antigen Typing
  Antibody Identification


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By End-user Insights

The hospitals and blood banks segment is estimated to witness significant growth during the forecast period.

The market is witnessing significant growth due to the escalating demand for blood typing in various healthcare applications. Hospitals and blood banks dominate the market landscape, accounting for the largest share, driven by the increasing need for blood transfusions in the treatment of chronic conditions and emergency cases. These reagents play a crucial role in diagnostic accuracy through agglutination reactions, hemolysis detection, and serological testing. Manufacturers focus on reagent manufacturing, concentration, and validation methods to ensure quality control and regulatory compliance. Technological advancements, such as enzyme immunoassay and automation systems, enhance test accuracy and reaction time. Monoclonal and polyclonal antibodies are integral to blood group typing, ensuring antibody specificity and minimizing false negatives and positives.

Reagent stability, incubation temperature, and sample preparation are essential factors in maintaining result interpretation and quality assurance. The market is expected to continue evolving, with a focus on improving test accuracy and reducing the prozone and postzone effects.

Request Free Sample

The Hospitals and blood banks segment was valued at USD 424.40 million in 2019 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 49% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market

The global ABO blood typing test kit market is experiencing robust growth, driven by rising prevalence of blood transfusions, increasing incidence of blood-related disorders, and expanding diagnostic testing capabilities in both developed and developing nations. The market, currently estimated at $1.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching a value exceeding $2.5 billion by the end of the forecast period. This expansion is fueled by technological advancements leading to faster, more accurate, and automated testing methods. The increasing adoption of point-of-care testing (POCT) devices contributes significantly to market growth, allowing for rapid blood type determination in various settings, including emergency rooms and remote areas. Furthermore, stringent regulatory frameworks promoting blood safety and the growing awareness of the importance of accurate blood typing before transfusions are key market drivers. The market is segmented by application (hospital, clinic) and type of test kit (positive stereotype, anti-stereotype), with hospitals currently dominating the application segment due to higher testing volumes. Geographic growth is expected to be fairly evenly distributed across regions, with North America and Europe maintaining substantial market shares due to established healthcare infrastructure and high healthcare expenditure. However, rapidly developing economies in Asia-Pacific, particularly China and India, are poised for significant market expansion, driven by growing healthcare investments and increasing adoption of advanced diagnostic technologies. Competition is moderate, with several key players vying for market share. The market faces challenges including the high cost of advanced testing kits and the potential for errors in manual testing procedures. However, ongoing research and development efforts are focused on mitigating these challenges through the introduction of cost-effective and highly accurate automated systems. The prevalence of infectious diseases also presents a constraint, as meticulous safety measures are essential during blood typing procedures. Despite these challenges, the long-term outlook for the ABO blood typing test kit market remains positive, propelled by sustained demand for accurate and rapid blood typing, expanding healthcare infrastructure globally, and the continuous development of innovative testing technologies. The market's growth trajectory underscores the critical role of accurate blood typing in ensuring safe and effective blood transfusions and overall patient care.

In 2021, there were an estimated 274 blood transfusion-associated adverse reactions in the United States that required any diagnostic or therapeutic intervention per 100,000 components transfused. This graph shows the estimated rate of blood transfusion-associated adverse reactions in the United States in 2019 and 2021, by type, per 100,000 components transfused.

The global blood group typing market is experiencing robust growth, driven by the increasing prevalence of blood transfusions and the rising demand for accurate and rapid blood typing methods. Technological advancements, such as the adoption of automated and high-throughput systems, are significantly improving the efficiency and accuracy of blood typing procedures, leading to faster turnaround times and reduced errors. Furthermore, the growing prevalence of chronic diseases requiring frequent blood transfusions and the increasing number of surgical procedures are contributing to market expansion. The market is segmented by type (manual, automated) and application (blood banks, hospitals, research). The automated segment is witnessing rapid growth due to its advantages in speed, accuracy, and efficiency. Hospitals and blood banks constitute the largest application segments, driven by their high volume of blood typing needs. Key players such as Agena Bioscience, Bio-Rad Laboratories, Danaher, Merck KGaA, and Ortho Clinical Diagnostics are strategically investing in research and development, mergers and acquisitions, and geographical expansion to solidify their market positions. This competitive landscape is fostering innovation and leading to the development of advanced blood typing technologies. The market's geographical distribution demonstrates significant regional variations. North America and Europe currently hold the largest market shares, attributed to well-established healthcare infrastructure, high adoption rates of advanced technologies, and increasing healthcare expenditure. However, developing economies in Asia-Pacific and the Middle East & Africa are exhibiting promising growth potential due to rising healthcare awareness, improving healthcare infrastructure, and increasing government initiatives aimed at enhancing healthcare services. While the market faces challenges such as stringent regulatory requirements and high costs associated with advanced technologies, the overall growth trajectory remains positive, fueled by unmet needs for efficient and precise blood typing solutions. We project sustained market expansion over the forecast period, driven by continued technological innovation and increasing healthcare demands globally.

ABO Blood Group Reagent Market Outlook

The global ABO blood group reagent market size is projected to witness significant growth from $820 million in 2023 to approximately $1.4 billion by 2032, with a compound annual growth rate (CAGR) of 6.2%. The primary growth drivers of this market include the rising prevalence of chronic diseases, increased demand for blood transfusions, and advancements in diagnostic technologies. As healthcare systems worldwide continue to improve and expand, the need for accurate blood typing and cross-matching becomes critical, further driving the market's expansion.

One of the pivotal factors driving the growth of the ABO blood group reagent market is the increasing incidence of chronic diseases and trauma cases requiring blood transfusions. With the aging global population, conditions such as cancer, cardiovascular diseases, and orthopedic surgeries are becoming more prevalent, necessitating frequent blood transfusions. This increases the demand for reliable ABO blood group reagents, which are essential for ensuring patient safety during transfusions. Additionally, increased awareness about blood donation and the safety of blood transfusions is contributing to the market's growth.

Advancements in diagnostic technologies and automated blood typing systems are also propelling the ABO blood group reagent market forward. Modern diagnostic laboratories and blood banks are adopting automated systems that offer high precision and efficiency in blood typing and cross-matching. These advancements reduce human errors, enhance throughput, and improve the overall quality of diagnostic services. The integration of advanced technologies such as artificial intelligence and machine learning in blood group typing is further expected to open new avenues for market growth.

Government initiatives and regulations promoting safe blood transfusion practices are another critical factor contributing to market growth. Stringent guidelines and protocols established by health authorities such as the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) ensure the implementation of reliable and accurate blood typing and cross-matching procedures. These regulations mandate the use of high-quality reagents, thus driving the demand for ABO blood group reagents.

The regional outlook of the ABO blood group reagent market highlights significant growth potential in various parts of the world. North America and Europe are anticipated to dominate the market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. Asia Pacific is expected to witness the highest growth rate, driven by an expanding healthcare sector, increasing awareness about blood donation, and supportive government policies. Latin America and the Middle East & Africa regions also present growth opportunities due to improving healthcare access and rising investment in healthcare infrastructure.

Product Type Analysis

The ABO blood group reagent market is segmented by product type into Anti-A Reagents, Anti-B Reagents, Anti-AB Reagents, Anti-D Reagents, and Others. Anti-A reagents hold a prominent position in the market due to their critical role in determining the presence of A antigens in blood samples. These reagents are crucial for ensuring compatibility in blood transfusions and organ transplants. The increasing demand for accurate blood typing in hospitals and diagnostic laboratories is driving the growth of the Anti-A reagents segment.

Anti-B reagents are also witnessing substantial demand as they are essential for detecting B antigens in blood samples. Accurate determination of B antigens is vital for preventing adverse reactions during blood transfusions. The rising prevalence of conditions requiring blood transfusions, such as anemia and trauma, is contributing to the growth of the Anti-B reagents segment. Moreover, advancements in reagent formulations are enhancing the sensitivity and specificity of Anti-B reagents, further boosting their market adoption.

The Anti-AB reagents segment is gaining traction due to its importance in identifying AB blood group individuals. These reagents play a crucial role in blood typing, especially in emergency situations where rapid and accurate identification of blood groups is necessary. The increasing number of surgeries and medical procedures requiring

Blood Group Typing Market Outlook

The global blood group typing market size was valued at approximately USD 2.1 billion in 2023 and is projected to reach around USD 3.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. This significant growth can be attributed to the increasing demand for safe blood transfusion, rising prevalence of chronic diseases, and advancements in technology related to blood group typing methodologies.

One of the primary growth factors of the blood group typing market is the rising incidence of chronic diseases and medical conditions that necessitate blood transfusion. Diseases such as cancer, hemophilia, and trauma cases require precise blood typing to ensure patient safety during transfusions. Furthermore, the growing number of surgical procedures, which often require blood transfusions, is another driving factor. The increasing adoption of blood group typing in prenatal screenings to prevent hemolytic disease in newborns is also contributing significantly to the market growth.

The advancements in technology are playing a crucial role in the blood group typing market. New methodologies such as polymerase chain reaction (PCR)-based techniques, microarray, and massively parallel sequencing have revolutionized the accuracy and efficiency of blood typing. These technological advancements reduce the risk of transfusion-related complications and improve patient outcomes. Moreover, the integration of artificial intelligence and machine learning in diagnostic processes is further enhancing the accuracy and speed of blood group typing, thereby fueling market growth.

Another critical factor contributing to the market growth is the increasing awareness and governmental initiatives promoting voluntary blood donation. Governments and NGOs are undertaking various programs to educate the public about the importance of blood donation and the need for safe transfusion practices. These initiatives are resulting in increased blood donation rates, which in turn is driving the demand for advanced blood group typing techniques. Additionally, the rising healthcare expenditure in developing countries is enabling the adoption of sophisticated blood typing technologies, further propelling market growth.

Regionally, North America is expected to hold the largest market share due to the high prevalence of chronic diseases, advanced healthcare infrastructure, and significant investment in research and development. Europe is also anticipated to witness substantial growth owing to the increasing number of blood donations and advancements in healthcare technology. The Asia Pacific region is projected to experience the highest growth rate, driven by the large population base, increasing awareness about blood donation, and improving healthcare facilities. Latin America and the Middle East & Africa are also poised for growth, albeit at a slower pace, due to ongoing development in healthcare infrastructure and rising awareness.

Product Analysis

The product segment of the blood group typing market is categorized into instruments and reagents & kits. Instruments include automated and semi-automated analyzers used in blood typing, while reagents & kits encompass various antibodies, antigen kits, and other consumables necessary for blood typing procedures. The demand for instruments is driven by the need for high-throughput and accurate testing in hospitals and diagnostic laboratories. Automated analyzers are particularly gaining traction due to their ability to process large volumes of samples efficiently and with precision.

Reagents & kits hold a significant share in the market due to their recurring demand in routine blood typing tests. Continuous advancements and innovations in reagents, such as the development of monoclonal antibodies, are enhancing the accuracy and reliability of blood typing tests. The availability of a wide range of reagent kits designed for various blood typing techniques, including PCR-based and microarray methods, is further driving the market growth. Additionally, the increasing use of reagents in research laboratories for developing new blood typing methodologies is contributing to the segment's expansion.

The instruments segment is anticipated to witness considerable growth during the forecast period, driven by technological advancements and the rising adoption of automated systems in healthcare settings. The integration of advanced software and artificial intelligence in these instruments is further improving their efficiency and accura

Analysis of the US blood-grouping reagents market showing a slight decline in 2024 but forecasting long-term growth to 4.6K tons and $335M by 2035, with insights on production, trade, and key suppliers.

Statistics illustrates the net export volume of Blood-Grouping Reagents in China from 2007 to 2024 by trade partner.

Blood Group Test Cards Market Outlook

As of 2023, the global blood group test cards market size is estimated to be around USD 1.2 billion and is projected to reach approximately USD 2.3 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period. A significant growth factor driving this market is the increasing prevalence of blood-related disorders and the rising demand for blood transfusions worldwide.

One of the primary growth factors for the blood group test cards market is the rising incidence of road accidents and trauma cases, which necessitate urgent blood transfusions and thus require rapid and accurate blood group testing. Moreover, the growing awareness about blood donation and the importance of maintaining an adequate blood supply in blood banks is bolstering the demand for blood group test cards. Technological advancements in blood grouping techniques, which enhance accuracy and reduce the time required for testing, are also contributing significantly to market expansion.

Another major driver for market growth is the increasing number of surgical procedures globally, which often require preoperative blood group testing. The expansion of healthcare infrastructure in emerging economies is playing a crucial role in market development. Government initiatives to improve healthcare services, coupled with increased healthcare spending, are creating favorable conditions for the growth of the blood group test cards market. Additionally, the rise in chronic diseases such as cancer, which may require frequent blood transfusions, further fuels the demand for blood group test cards.

In the context of regional outlook, North America holds a substantial share of the global blood group test cards market, driven by advanced healthcare infrastructure and high awareness about blood safety. Europe follows closely, benefiting from similar factors and robust government initiatives. The Asia Pacific region is anticipated to witness the highest growth rate due to the burgeoning population, increasing healthcare expenditure, and improving healthcare infrastructure. The Middle East & Africa and Latin America are also expected to exhibit significant growth, supported by rising healthcare awareness and investments in healthcare infrastructure.

Blood Transfusion Diagnostics play a crucial role in ensuring the safety and compatibility of blood transfusions, which are vital in medical emergencies and chronic disease management. The advancements in blood transfusion diagnostics have significantly improved the accuracy and speed of identifying blood types and detecting potential transfusion-transmitted infections. This progress is essential in reducing the risks associated with blood transfusions and enhancing patient outcomes. The integration of advanced diagnostic technologies in blood transfusion practices is also contributing to the overall efficiency of healthcare systems, ensuring that patients receive the right type of blood in a timely manner.

Product Type Analysis

The blood group test cards market can be segmented into three primary product types: ABO Blood Group Test Cards, Rh Blood Group Test Cards, and Combined ABO and Rh Blood Group Test Cards. The ABO Blood Group Test Cards segment is expected to hold a significant market share due to its essential role in identifying the primary blood groups (A, B, AB, and O). These test cards are widely used in various healthcare settings, making them a staple in blood grouping procedures.

Rh Blood Group Test Cards are crucial for identifying the Rh factor, which is vital for ensuring compatibility in blood transfusions. The increasing awareness about the importance of Rh factor testing, particularly in prenatal care to prevent hemolytic disease of the newborn, is driving the demand for these test cards. Technological advancements in Rh factor detection are also contributing to the growth of this segment.

The Combined ABO and Rh Blood Group Test Cards segment is anticipated to exhibit robust growth during the forecast period. These test cards offer the advantage of simultaneously determining both the ABO blood group and the Rh factor, thus providing a comprehensive blood grouping solution. Their growing adoption in hospitals, blood banks, and diagnostic laboratories can be attributed to their efficiency and convenience, which streamline the blood typing process and reduce the margin for error.

Snapshot img

Blood Market Size 2025-2029

The blood market size is valued to increase USD 2.6 billion, at a CAGR of 5.7% from 2024 to 2029. Rising number of hospitals and blood banks will drive the blood market.

Major Market Trends & Insights

North America dominated the market and accounted for a 40% growth during the forecast period.
By Product - WBC and P segment was valued at USD 4.34 billion in 2023
By End-user - Hospitals segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 60.49 million
Market Future Opportunities: USD 2597.20 million
CAGR : 5.7%
North America: Largest market in 2023

Market Summary

The market represents a dynamic and evolving landscape, driven by the continuous demand for blood and its components to cater to various medical applications. Core technologies, such as automated blood collection systems and advanced blood typing techniques, are revolutionizing the industry, ensuring a more efficient and accurate blood supply chain. Meanwhile, the increasing number of hospitals and blood banks, driven by the rising awareness about blood donation, is fueling market growth. However, challenges persist, including the low availability of blood storage and transfusion facilities in rural areas, which hampers access to essential blood services for many communities. As of 2021, approximately 38% of the global population is eligible to donate blood, yet only around 10% actually do so each year. This underscores the need for continued innovation and investment in the market to address these challenges and ensure a reliable and accessible blood supply for all.

What will be the Size of the Blood Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Blood Market Segmented and what are the key trends of market segmentation?

The blood industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductWBC and PBlood screening productsBlood typing productsSource plasma collectionEnd-userHospitalsAmbulatory surgical centers (ASCs)OthersApplicationTherapeuticDiagnosticResearch and developmentGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaIndiaJapanSouth KoreaRest of World (ROW)

By Product Insights

The wbc and p segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth, with the whole blood and plasma segments showing steady expansion. Whole blood, which accounts for a substantial portion of the market, is in high demand due to its usage in various applications, including surgical procedures, blood transfusions, and trauma care. Trauma is a leading cause of death and injury worldwide, with over 5 million fatalities and 1 billion people requiring medical attention each year, according to the World Health Organization. The demand for coagulation testing, differential blood count, plasma protein electrolytes, leukocyte activation, hematocrit levels, blood cell morphology, blood glucose monitoring, complete blood count, serum iron levels, blood chemistry panel, ferritin blood test, blood lipid profile, d-dimer assay, blood viscosity measurement, vascular endothelial function, hematopoietic stem cells, thrombocyte production, blood type determination, blood flow dynamics, blood pressure regulation, blood oxygen saturation, hemoglobin concentration, erythropoiesis stimulation, platelet aggregation, fibrinogen levels, blood gas analysis, and blood coagulation factors is driving the market's expansion. Furthermore, advancements in technology and research are leading to innovations in blood testing and analysis, creating new opportunities for market growth. For instance, there is a growing interest in point-of-care testing, which allows for quick and accurate blood analysis outside of traditional laboratory settings. This trend is expected to gain momentum in the coming years, particularly in developing countries where access to healthcare facilities is limited. Additionally, the increasing prevalence of chronic diseases, such as cancer and diabetes, is driving the demand for regular blood testing and analysis. According to the American Cancer Society, there will be an estimated 1.9 million new cancer cases in the US alone in 2021. This growing patient population requires regular blood tests to monitor their condition and manage their treatment effectively. Moreover, the aging population is another significant factor fueling the growth of the market. As people age, they are more susceptible to various health conditions that require regular blood testing and analysis. According to the World Health Organization, the global population aged 60 ye

The global blood grouping and phenotyping reagents market is experiencing robust growth, driven by the increasing prevalence of blood-related disorders, expanding blood transfusion services, and the rising demand for accurate blood typing in various healthcare settings. The market is segmented by application (hospital, blood bank, R&D, others) and type (blood phenotyping reagents, blood grouping reagents). Hospitals and blood banks constitute the largest segments, reflecting the crucial role of accurate blood typing in safe blood transfusions and patient care. The increasing adoption of advanced technologies like automated blood typing systems and the growing focus on personalized medicine are further fueling market expansion. Research and development activities are also contributing significantly, with ongoing efforts to improve reagent accuracy, sensitivity, and efficiency. While the market faces constraints such as stringent regulatory approvals and the high cost of advanced reagents, the overall outlook remains positive, projecting substantial growth in the coming years. We estimate the 2025 market size to be approximately $2.5 billion, based on market trends and the available information. A conservative CAGR of 7% is projected for the forecast period (2025-2033), resulting in significant market expansion by 2033. Geographic regions like North America and Europe currently hold a significant market share, owing to well-established healthcare infrastructure and higher adoption rates. However, emerging economies in Asia-Pacific are expected to exhibit accelerated growth due to rising healthcare expenditure and increasing awareness about blood transfusion safety. The competitive landscape is characterized by the presence of both established multinational corporations and smaller specialized players. Companies are focusing on strategic partnerships, mergers and acquisitions, and product innovation to enhance their market position. The development of novel reagents with improved functionalities and automation capabilities will be key to sustaining competitive advantage in the future. The rising demand for point-of-care testing and the development of rapid diagnostic tests are also expected to shape the future of the blood grouping and phenotyping reagents market. This demand for faster, more efficient solutions underscores the ongoing efforts to improve blood typing technologies and streamline processes within hospitals and blood banks. The overall market trajectory indicates a significant growth opportunity for stakeholders involved in the manufacturing, distribution, and application of blood grouping and phenotyping reagents.